AriBio joins Eli Lilly's TuneLab platform to advance neuroscience drug discovery

AriBio has joined Lilly TuneLab, Eli Lilly's AI drug discovery platform, to support its Alzheimer's and Lewy body dementia pipeline. The platform uses federated learning, letting companies share model training without exposing private data.